New multicenter project: BIOTRABIS

New multicenter project:BIOTRABIS (Biomarkers of traumatic Brain injury-Spain)

This is a longitudinal, prospective, non-observational, without drugs, multicenter study, which include patients with mild TBI of less than twenty-four hours of evolution, recruited in the emergency services of the participating centers.

more information: http://www.biotrabis.com

New H2020 project: AFFECT-EU

New H2020 project : AFFECT-EU

Digital, risked-based screening for Atrial Fibrillation in the European Community

Atrial fibrillation (AF) is an increasingly common arrhythmia in the aging European population. Its prevalence will more than double by the year 2050 affecting 5% of EU women and men aged ≥65 years. AF carries a high risk of stroke, heart failure, and dementia, which result in a significant loss of quality-adjusted life years and high mortality. The EU guiding principles for active aging (no. 17468/12) recommend disease prevention to maximise healthy life, and early detection of AF is recommended by the European Society of Cardiology (ESC). Nonetheless, to date, a risked-based screening strategy is lacking.

AFFECT-EU’s major goal is the development of a risk-based, accurate, and ready for implementation AF screening algorithm, using digital devices, for early AF detection in the community.